Probiotec (ASX:PBP) Trading 1% Higher

Probiotec Limited (ASX:PBP) shares shot up 1% during trading on Monday . The stock traded as high as A$2.06 ($1.46) and last traded at A$2.06 ($1.46), 68,882 shares were traded during trading. The stock had previously closed at A$2.04 ($1.45).

The company has a debt-to-equity ratio of 61.62, a current ratio of 2.45 and a quick ratio of 1.44. The company has a market capitalization of $148.81 million and a price-to-earnings ratio of 11.37. The business’s 50-day moving average price is A$1.96 and its two-hundred day moving average price is A$1.71.

The business also recently declared a Final dividend, which was paid on Thursday, October 31st. Investors of record on Thursday, October 31st were given a dividend of $0.025 per share. This represents a yield of 1.53%. The ex-dividend date was Thursday, October 24th. Probiotec’s dividend payout ratio is currently 22.86%.

Probiotec Company Profile (ASX:PBP)

Probiotec Limited develops, manufactures, and sells pharmaceutical, consumer health, and nutraceutical products in Australia and internationally. The company operates in three segments: Branded Pharmaceuticals, Contract Manufacture, and Obesity and Weight Management. It primarily engages in the contract manufacturing of pharmaceutical, food, and animal nutrition products for pharmaceutical and food companies; manufacture and sale of a range of obesity and weight management products in various channels, including FMCG, pharmacy, health food stores, and online; and provision of Celebrity Slim and Impromy weight loss programs.

See Also: What is the Hang Seng index?  

Receive News & Ratings for Probiotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Probiotec and related companies with MarketBeat.com's FREE daily email newsletter.